Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Mostrar otras versiones (4)

BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. MAIN BODY: This commentary of highlights has resulted in 21 different topics selected by each coauthoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyohara, Jun, Al-Qahtani, Mohammed, Huang, Ya-Yao, Cazzola, Emiliano, Todde, Sergio, Furumoto, Shozo, Mikolajczak, Renata, Decristoforo, Clemens, Gillings, Nic, Yang, Min, Reilly, Raymond, Duatti, Adriano, Denkova, Antonia, Schirrmacher, Ralf, Carlucci, Giuseppe, Seimbille, Yann, Liu, Zhaofei, Ellis, Beverley, Cornelissen, Bart T., Kopka, Klaus, Bernardes, Emerson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526771/
https://www.ncbi.nlm.nih.gov/pubmed/36182995
http://dx.doi.org/10.1186/s41181-022-00177-w
Descripción
Sumario:BACKGROUND: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. MAIN BODY: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. CONCLUSION: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

Ejemplares similares